Results 241 to 250 of about 1,222,727 (300)

The Immunology of Alpha‐Gal Syndrome: History, Tick Bites, IgE, and Delayed Anaphylaxis to Mammalian Meat

open access: yesImmunological Reviews, Volume 332, Issue 1, July 2025.
ABSTRACT The primary features of the alpha‐gal syndrome (AGS) are (i) The IgE ab that are causally related to anaphylaxis with infusions of Cetuximab are specific for galactose alpha‐1,3‐galactose. (ii) In the USA, this IgE ab is induced by bites of the tick Amblyomma americanum. (iii) The anaphylactic reactions to food derived from non‐primate mammals
Thomas A. E. Platts‐Mills   +3 more
wiley   +1 more source

Inhibitory effects against zoonotic bacteria by Oroxylum indicum ointment and effects to dog wound. [PDF]

open access: yesJ Adv Pharm Technol Res
Sithisarn P   +3 more
europepmc   +1 more source

Dad's legacy: Epigenetic reprogramming and paternal inflammatory memory in offspring health

open access: yesJournal of Internal Medicine, Volume 298, Issue 1, Page 16-30, July 2025.
Abstract Over the past decade, numerous reports have highlighted intergenerational and even transgenerational epigenetic effects resulting from parental exposure to diets, toxins, and stress. In many cases, these parentally induced phenotypes do not seem to confer an obvious benefit, making it challenging to understand the evolutionary drivers behind ...
Shamila D. Alipoor   +3 more
wiley   +1 more source

Resistance in zoonotic bacteria

open access: yes
As in previous years, resistance levels in Campylobacter jejuni isolated from humans were higher than in isolates from broilers and cattle, and among human isolates, resistance was higher in travel-associated cases compared to domestically acquired cases.Compared to 2022, the percentage of fully sensitive C.
Pessoa, Joana   +2 more
openaire   +1 more source

Rice‐derived SARS‐CoV‐2 glycoprotein S1 subunit vaccine elicits humoral and cellular immune responses

open access: yesPlant Biotechnology Journal, Volume 23, Issue 7, Page 2570-2582, July 2025.
Summary Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus causing COVID‐19, has been spreading and mutating globally despite the expedited approval of many commercial vaccines. Therefore, developing safe, effective and affordable vaccines remains essential to meet the global demand, particularly in developing countries.
Li Song   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy